-
Something wrong with this record ?
Pelargonidin activates the AhR and induces CYP1A1 in primary human hepatocytes and human cancer cell lines HepG2 and LS174T
A. Kamenickova, E. Anzenbacherova, P. Pavek, AA. Soshilov, MS. Denison, P. Anzenbacher, Z. Dvorak,
Language English Country Netherlands
Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- MeSH
- Transcriptional Activation drug effects MeSH
- Anthocyanins pharmacology MeSH
- Hep G2 Cells MeSH
- Cytochrome P-450 CYP1A1 biosynthesis MeSH
- Enzyme Induction MeSH
- Hepatocytes drug effects enzymology MeSH
- Microsomes, Liver enzymology MeSH
- Kinetics MeSH
- Humans MeSH
- Ligands MeSH
- RNA, Messenger biosynthesis MeSH
- Liver Neoplasms enzymology MeSH
- Polychlorinated Dibenzodioxins pharmacology MeSH
- Primary Cell Culture MeSH
- Promoter Regions, Genetic drug effects MeSH
- Receptors, Aryl Hydrocarbon drug effects metabolism MeSH
- Signal Transduction drug effects MeSH
- Intestinal Neoplasms enzymology MeSH
- Transfection MeSH
- Basic Helix-Loop-Helix Transcription Factors drug effects metabolism MeSH
- Dose-Response Relationship, Drug MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, N.I.H., Extramural MeSH
We examined the effects of anthocyanidins (cyanidin, delphinidin, malvidin, peonidin, petunidin, pelargonidin) on the aryl hydrocarbon receptor (AhR)-CYP1A1 signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells. AhR-dependent reporter gene expression in transfected HepG2 cells was increased by pelargonidin in a concentration-dependent manner at 24h. Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (TCDD), the most potent activator of AhR. CYP1A1 and CYP1A2 mRNAs were also increased by pelargonidin in three primary human hepatocytes cultures (approximately 5% of TCDD potency) and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of CYP1A1 enzyme. Ligand binding analysis demonstrated that pelargonidin was a weak ligand of AhR. Enzyme kinetic analyses using human liver microsomes revealed inhibition of CYP1A1 activity by delphinidin (IC50 78 μM) and pelargonidin (IC50 33 μM). Overall, although most anthocyanidins had no effects on AhR-CYP1A1 signaling, pelargonidin can bind to and activate the AhR and AhR-dependent gene expression, and pelargonidin and delphinidin inhibit the CYP1A1 catalytic activity.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13023954
- 003
- CZ-PrNML
- 005
- 20180214202129.0
- 007
- ta
- 008
- 130703s2013 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.toxlet.2013.01.020 $2 doi
- 035 __
- $a (PubMed)23419638
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Kamenickova, Alzbeta $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Slechtitelu 11, 783 71 Olomouc, Czech Republic.
- 245 10
- $a Pelargonidin activates the AhR and induces CYP1A1 in primary human hepatocytes and human cancer cell lines HepG2 and LS174T / $c A. Kamenickova, E. Anzenbacherova, P. Pavek, AA. Soshilov, MS. Denison, P. Anzenbacher, Z. Dvorak,
- 520 9_
- $a We examined the effects of anthocyanidins (cyanidin, delphinidin, malvidin, peonidin, petunidin, pelargonidin) on the aryl hydrocarbon receptor (AhR)-CYP1A1 signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells. AhR-dependent reporter gene expression in transfected HepG2 cells was increased by pelargonidin in a concentration-dependent manner at 24h. Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (TCDD), the most potent activator of AhR. CYP1A1 and CYP1A2 mRNAs were also increased by pelargonidin in three primary human hepatocytes cultures (approximately 5% of TCDD potency) and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of CYP1A1 enzyme. Ligand binding analysis demonstrated that pelargonidin was a weak ligand of AhR. Enzyme kinetic analyses using human liver microsomes revealed inhibition of CYP1A1 activity by delphinidin (IC50 78 μM) and pelargonidin (IC50 33 μM). Overall, although most anthocyanidins had no effects on AhR-CYP1A1 signaling, pelargonidin can bind to and activate the AhR and AhR-dependent gene expression, and pelargonidin and delphinidin inhibit the CYP1A1 catalytic activity.
- 650 _2
- $a anthokyaniny $x farmakologie $7 D000872
- 650 _2
- $a transkripční faktory bHLH $x účinky léků $x metabolismus $7 D051792
- 650 _2
- $a cytochrom P-450 CYP1A1 $x biosyntéza $7 D019363
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a enzymová indukce $7 D004790
- 650 _2
- $a buňky Hep G2 $7 D056945
- 650 _2
- $a hepatocyty $x účinky léků $x enzymologie $7 D022781
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a střevní nádory $x enzymologie $7 D007414
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a nádory jater $x enzymologie $7 D008113
- 650 _2
- $a jaterní mikrozomy $x enzymologie $7 D008862
- 650 _2
- $a primární buněčná kultura $7 D061251
- 650 _2
- $a promotorové oblasti (genetika) $x účinky léků $7 D011401
- 650 _2
- $a messenger RNA $x biosyntéza $7 D012333
- 650 _2
- $a receptory aromatických uhlovodíků $x účinky léků $x metabolismus $7 D018336
- 650 _2
- $a signální transdukce $x účinky léků $7 D015398
- 650 _2
- $a polychlorované dibenzodioxiny $x farmakologie $7 D000072317
- 650 _2
- $a aktivace transkripce $x účinky léků $7 D015533
- 650 _2
- $a transfekce $7 D014162
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Anzenbacherová, Eva $u - $7 stk2008428613 $4
- 700 1_
- $a Pavek, Petr $u -
- 700 1_
- $a Soshilov, Anatoly A $u -
- 700 1_
- $a Denison, Michael S $u -
- 700 1_
- $a Anzenbacher, Pavel $u - $7 xx0034447 $4
- 700 1_
- $a Dvorak, Zdenek $u -
- 773 0_
- $w MED00004537 $t Toxicology letters $x 1879-3169 $g Roč. 218, č. 3 (2013), s. 253-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23419638 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130703 $b ABA008
- 991 __
- $a 20130709094732 $b ABA008
- 999 __
- $a ok $b bmc $g 987634 $s 822334
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 218 $c 3 $d 253-9 $i 1879-3169 $m Toxicology letters $n Toxicol Lett $x MED00004537
- LZP __
- $a Pubmed-20130703